The Board of Directors helps set and guide the strategic direction for the Company. The Board ensures timely disclosures and transparent accounting policies. It reviews broad corporate policies, overall performance, corporate social responsibility measures and other areas of significance to the organisation.
The Board comprises individuals of diverse backgrounds with broad relevant experience.
Independent Directors and their key areas of focus:
Anupam Puri
Governance, corporate strategy
and driving agenda for Board and
Board Committee meetings and
its improvement
Kalpana Morparia
Internal audit and control
Dr. Omkar Goswami
Finance, internal controls and risk management
Ravi Bhoothalingam
Compliance and Ombudsperson for the Whistle Blower Policy of the Company
Dr. J.P. Moreau
Pharma regulatory compliance and its improvement
Dr. Bruce L.A. Carter
Enterprise Risk Management
Dr. Ashok S. Ganguly
Science, Technology and Operations
During the year, an external professional agency was engaged to assist the Board in evaluating its processes and effectiveness.
